Improved Rehabilitation After Spinal Surgery in Adolescents

August 27, 2021 updated by: Nantes University Hospital

Improved Rehabilitation After Spinal Surgery in Adolescents: Prospective Observational Epidemiological Study of a Protocol Without Opioid

Impact of the OFA technique on postoperative recovery from adolescent spine surgery and the incidence of chronic postoperative pain.

Study Overview

Status

Completed

Detailed Description

RACAROFA is an observational, prospective study based on the hypothesis that the OFA technique effectively improves the long-term postoperative rehabilitation of adolescents and reduces the incidence of CPSP. A prospective French multicentre study on this topic is currently not feasible, as other multicentre studies (pain monitoring by the ANI, blood saving strategy) would interfere with potential recruitment.

Study Type

Observational

Enrollment (Actual)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Loire-Atlantique
      • Nantes, Loire-Atlantique, France, 44000
        • Nantes University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

- As the study concerns a specifically paediatric pathology, minors will not be excluded from the study.

Description

Inclusion Criteria:

  • Patent with idiopathic or secondary surgical scoliosis
  • Management by the paediatric anaesthesia team at the Mother and Child - Hospital of the University Hospital of Nantes
  • Non-opposition to inclusion in the study collected orally from the patient and parents
  • Satisfying oral and written comprehension of the French language, without interpreter
  • Ability to participate in a telephone interview

Exclusion Criteria:

  • Patient that does not understand French correctly
  • Patient unable to express himself/herself correctly in French
  • Patient with a non-scoliotic surgical spinal pathology
  • Refusal to participate in the study
  • Absence of a record of non-opposition to participation in the study from the patient and his or her parents
  • Cerebral palsy or any other condition that does not allow participation in a telephone interview without particular difficulty.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of chronic postsurgical pain after surgery in the adolescent cohort included in the study RACAROFA
Time Frame: Three months after surgery
Pain at the surgical site, rated at more than 3 on a numerical scale graduated from 0 (no pain) to 10 (maximum pain) during a telephone interview.
Three months after surgery
Incidence of chronic postsurgical pain after surgery in the adolescent cohort included in the study RACAROFA
Time Frame: Sixth months after surgery
Pain at the surgical site, rated at more than 3 on a numerical scale graduated from 0 (no pain) to 10 (maximum pain) during a telephone interview.
Sixth months after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Occurence of a postoperative opioid-related adverse event
Time Frame: Within the first 48 hours after extubation

postoperative hypoxemia or PONV (postoperative nausea and vomiting) or excessive sedation. Postoperative hypoxemia is defined as an oxygen saturation (SpO2) < 95% with a need for oxygen supplementation within the first 48h after extubation.

PONV is defined by use of antiemetics of PONV within the first 48h after extubation.

Excessive sedation is defined by a score of 3 in a scale of sedation wich is S1 awake, S2 mild drowsiness, S3 non awakenable.

Within the first 48 hours after extubation
Level of preoperative quality of life
Time Frame: Three month after surgery
SRS-30 score (Scoliosis Research Society Health-Related Quality of Life Questionnaire), during a telephone interview. Score between 1 and 5 where 5 is the higher level of quality of live.
Three month after surgery
Postoperative opioid consumption
Time Frame: Within the 2 first weeks postsurgery
Cumulative consumption of opioid in mg/kg.
Within the 2 first weeks postsurgery
Level of preoperative quality of life: SRS-30 score
Time Frame: Sixth month after surgery
SRS-30 score (Scoliosis Research Society Health-Related Quality of Life Questionnaire), during a telephone interview. Score between 1 and 5 where 5 is the higher level of quality of live.
Sixth month after surgery
Postoperative rehabilitation
Time Frame: Within the first 2 weeks postsurgery
Number of days between surgery and first deambulation
Within the first 2 weeks postsurgery
Length of stay in the hospital
Time Frame: Within the first 2 weeks postsurgery
Number of days in the hospital.
Within the first 2 weeks postsurgery
Level of preoperative and postoperative anxiety in the adolescent cohort included in the study RACAROFA
Time Frame: Two weeks before surgery
State trait anxiety Inventory for Children (STAIC) score evaluated during a telephone interview. Score between 20 and 60, where 60 is the higher level of anxiety
Two weeks before surgery
Level of preoperative and postoperative anxiety in the adolescent cohort included in the study RACAROFA
Time Frame: three months after surgery
State trait anxiety Inventory for Children (STAIC) score evaluated during a telephone interview. Score between 20 and 60, where 60 is the higher level of anxiety
three months after surgery
Level of preoperative and postoperative anxiety in the adolescent cohort included in the study RACAROFA
Time Frame: sixth months after surgery
State trait anxiety Inventory for Children (STAIC) score evaluated during a telephone interview. Score between 20 and 60, where 60 is the higher level of anxiety
sixth months after surgery
Incidence of postoperative neuropathic pain in the adolescent cohort included in the study RACAROFA.
Time Frame: Three months after surgery
Modified DN4 score superior at 4.
Three months after surgery
Incidence of postoperative neuropathic pain in the adolescent cohort included in the study RACAROFA.
Time Frame: Six months after surgery
Modified DN4 score superior at 4.
Six months after surgery
Postoperative antalgics consumption other than opioid
Time Frame: Within the first 2 weeks postsurgery
Cumulative antalgics consumption other than opioid.
Within the first 2 weeks postsurgery
Incidence of preoperative pain in the adolescent cohort included in the study RACAROFA.
Time Frame: Two weeks before surgery
Back pain, rated at more than 3 on a numerical scale graduated from 0 (no pain) to 10 (maximum pain) during a telephone interview.
Two weeks before surgery
Level of preoperative and postoperative catastrophism in the adolescent cohort included in the study RACAROFA.
Time Frame: Two weeks before surgery, three and sixth months after surgery
Pain castrophizing scale for adolescent, score evaluated during a telephone interview. Score between 0 and 52, where 52 is the higher level of catastrophism.
Two weeks before surgery, three and sixth months after surgery
Level of preoperative and postoperative catastrophism in the adolescent cohort included in the study RACAROFA.
Time Frame: three months after surgery
Pain castrophizing scale for adolescent, score evaluated during a telephone interview. Score between 0 and 52, where 52 is the higher level of catastrophism.
three months after surgery
Level of preoperative and postoperative catastrophism in the adolescent cohort included in the study RACAROFA.
Time Frame: sixth months after surgery
Pain castrophizing scale for adolescent, score evaluated during a telephone interview. Score between 0 and 52, where 52 is the higher level of catastrophism.
sixth months after surgery
Level of preoperative and postoperative catastrophism in one of the parents of each adolescent included in the study RACAROFA.
Time Frame: Two weeks before surgery, three and sixth months after surgery
Pain castrophizing scale for adult, score evaluated during a telephone interview. Score between 0 and 52, where 52 is the higher level of catastrophism.
Two weeks before surgery, three and sixth months after surgery
Level of preoperative and postoperative catastrophism in one of the parents of each adolescent included in the study RACAROFA.
Time Frame: three months after surgery
Pain castrophizing scale for adult, score evaluated during a telephone interview. Score between 0 and 52, where 52 is the higher level of catastrophism.
three months after surgery
Level of preoperative and postoperative catastrophism in one of the parents of each adolescent included in the study RACAROFA.
Time Frame: sixth months after surgery
Pain castrophizing scale for adult, score evaluated during a telephone interview. Score between 0 and 52, where 52 is the higher level of catastrophism.
sixth months after surgery
Level of preoperative quality of life.
Time Frame: Two weeks before surgery
SRS-22 score (Scoliosis Research Society Health-Related Quality of Life Questionnaire), during a telephone interview. Score between 1 and 5 where 5 is the higher level of quality of live
Two weeks before surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Corine LEJUS, PUPH, CHU de Nantes
  • Principal Investigator: Guy LETELLIER, PH, ESEAN

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 18, 2019

Primary Completion (Actual)

August 1, 2021

Study Completion (Actual)

August 1, 2021

Study Registration Dates

First Submitted

November 14, 2019

First Submitted That Met QC Criteria

December 2, 2019

First Posted (Actual)

December 3, 2019

Study Record Updates

Last Update Posted (Actual)

August 30, 2021

Last Update Submitted That Met QC Criteria

August 27, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

3
Subscribe